Sino Medical Sciences Technology In (688108) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.21x

Sino Medical Sciences Technology In (688108) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥6.63 Million (capex CN¥6.63 Million ) from operating cash flow of CN¥31.52 Million. Explore how much does Sino Medical Sciences Technology In reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.21x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥6.63 Million
Capex + Investments

Operating Cash Flow

CN¥31.52 Million
CNY

Capital Expenditures

CN¥6.63 Million
CNY

Sino Medical Sciences Technology In Cash Flow Reinvestment Rate (2016–2024)

Historical reinvestment intensity for Sino Medical Sciences Technology In across 7 annual periods. Also explore 688108 total asset value for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Sino Medical Sciences Technology In (2016–2024)

Year-by-year capital reinvestment analysis for Sino Medical Sciences Technology In. For live market cap and broader valuation context, see Sino Medical Sciences Technology In market capitalisation.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2024 0.53x CN¥70.09 Million CN¥131.24 Million CN¥70.02 Million ▼ -88.4%
2023 4.59x CN¥260.71 Million CN¥56.84 Million CN¥67.67 Million ▲ +174.6%
2020 1.67x CN¥117.78 Million CN¥70.51 Million CN¥112.78 Million ▲ +24.2%
2019 1.34x CN¥185.04 Million CN¥137.61 Million CN¥180.04 Million ▼ -63.4%
2018 3.68x CN¥358.87 Million CN¥97.56 Million CN¥98.87 Million ▼ -23.0%
2017 4.78x CN¥336.00 Million CN¥70.32 Million CN¥76.25 Million ▲ +131.5%
2016 2.06x CN¥87.19 Million CN¥42.24 Million CN¥44.32 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow